Trial intelligence / Profile preview

Pantoprazole vs Ranitidine on Anti-platelet Effect of Clopidogrel

NCT02733640Completed

Sponsor
Seoul National University Bundang Hospital
Start
Oct 2012
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of pantoprazole in coronary artery disease (CAD) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Number of participants with more than 5 Ω of impedance after intervention at 8 days. Started Oct 2012; status: completed.

02

Drugs

pantoprazole
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02733640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02733640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call